Dr Jeffrey Bishop

Founded in 1996 as a humble family business, Erchonia Corporation has blossomed into a prominent international enterprise while remaining steadfast in our commitment to the foundational principles that have propelled us to our current zenith. Central to our mission is the genuine advancement of Low Level Laser Therapy (3LT®) through rigorous scientific and clinical research, positioning Erchonia as an undisputed global leader in the realm of Low-Level Laser Therapy (LLLT) technology.

The bedrock of our company’s ethos is characterized by unwavering integrity, relentless diligence, unwavering commitment, and an unyielding pursuit of quality. These traits are palpable in the stringent processes we meticulously adhere to, facilitating the transformation of research hypotheses into viable, agency-approved products and treatment methodologies. In a testament to our all-encompassing approach, Erchonia Corporation functions as the manufacturer, marketer, developer, promoter, creator, and ultimate end-user of all our innovative products.